AU5058400A - Pharmaceutical composition containing an extrusion additive - Google Patents

Pharmaceutical composition containing an extrusion additive

Info

Publication number
AU5058400A
AU5058400A AU50584/00A AU5058400A AU5058400A AU 5058400 A AU5058400 A AU 5058400A AU 50584/00 A AU50584/00 A AU 50584/00A AU 5058400 A AU5058400 A AU 5058400A AU 5058400 A AU5058400 A AU 5058400A
Authority
AU
Australia
Prior art keywords
pharmaceutical composition
composition containing
extrusion additive
extrusion
additive
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU50584/00A
Inventor
Thomas Backensfeld
Stefan Hulsmann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Schering AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering AG filed Critical Schering AG
Publication of AU5058400A publication Critical patent/AU5058400A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Disclosed are pharmaceutical compositions which can be obtained by mixing and mutually melt extruding at least one active substance with at least one extrusion additive from the group of polyalcohols that are esterified with fatty acids.
AU50584/00A 1999-03-31 2000-03-31 Pharmaceutical composition containing an extrusion additive Abandoned AU5058400A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19916383A DE19916383A1 (en) 1999-03-31 1999-03-31 Pharmaceutical composition with an extrusion
DE19916383 1999-03-31
PCT/DE2000/001028 WO2000057853A2 (en) 1999-03-31 2000-03-31 Pharmaceutical composition containing an extrusion additive

Publications (1)

Publication Number Publication Date
AU5058400A true AU5058400A (en) 2000-10-16

Family

ID=7904236

Family Applications (1)

Application Number Title Priority Date Filing Date
AU50584/00A Abandoned AU5058400A (en) 1999-03-31 2000-03-31 Pharmaceutical composition containing an extrusion additive

Country Status (9)

Country Link
EP (1) EP1165055B1 (en)
JP (1) JP2002540138A (en)
AT (1) ATE306907T1 (en)
AU (1) AU5058400A (en)
DE (2) DE19916383A1 (en)
DK (1) DK1165055T3 (en)
ES (1) ES2251377T3 (en)
NO (1) NO20014726L (en)
WO (1) WO2000057853A2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20020083171A (en) * 2000-03-08 2002-11-01 아베데 파르마 게엠베하 운트 콤파니 카게 Pharmaceutical preparations containing saccharose fatty acid esters for controlling the release of active ingredients
EP1479380B1 (en) * 2003-05-19 2007-05-09 Euro-Celtique S.A. Use of soaps such as magnesium stearate for increasing the release of drugs
ES2685472T3 (en) * 2008-12-05 2018-10-09 Bayer Intellectual Property Gmbh Extruded with needle-shaped active substances
WO2012120365A1 (en) * 2011-03-07 2012-09-13 Aurobindo Pharma Limited Stable pharmaceutical composition comprising ethinyl estradiol
GB201900389D0 (en) * 2019-01-11 2019-02-27 Queens Univ Of Belfast Solvent and water-free lipid-based nanoparticles and their methods of manufacture

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4629621A (en) * 1984-07-23 1986-12-16 Zetachron, Inc. Erodible matrix for sustained release bioactive composition
AU3432689A (en) * 1988-03-24 1989-10-16 Bukh Meditec A/S Controlled release composition
WO1993011749A1 (en) * 1991-12-18 1993-06-24 Warner-Lambert Company A process for the preparation of a solid dispersion
CA2182282C (en) * 1994-02-16 2006-04-18 Jacqueline E. Briskin Process for preparing fine particle pharmaceutical formulations
JPH0853357A (en) * 1994-08-08 1996-02-27 Ota Seiyaku Kk Fast-soluble sodium alginate solid preparation for oral administration
DE19504832A1 (en) * 1995-02-14 1996-08-22 Basf Ag Solid drug preparations
DE19531277A1 (en) * 1995-08-25 1997-02-27 Basf Ag Use of lipids as an aid in the production of solid dosage forms by the melt extrusion process
DE19705538C1 (en) * 1997-02-14 1998-08-27 Goedecke Ag Process for the separation of active substances in solid pharmaceutical preparations
DE19913606A1 (en) * 1999-03-25 2000-09-28 Basf Ag Powdery solubilization aids for solid pharmaceutical dosage forms

Also Published As

Publication number Publication date
DK1165055T3 (en) 2006-02-27
DE50011380D1 (en) 2006-03-02
EP1165055A2 (en) 2002-01-02
NO20014726L (en) 2001-11-14
ATE306907T1 (en) 2005-11-15
ES2251377T3 (en) 2006-05-01
WO2000057853A3 (en) 2001-02-22
JP2002540138A (en) 2002-11-26
WO2000057853A2 (en) 2000-10-05
EP1165055B1 (en) 2005-10-19
DE19916383A1 (en) 2000-10-05
NO20014726D0 (en) 2001-09-28

Similar Documents

Publication Publication Date Title
EP0179470A3 (en) Thermoplastic polyetherimide ester elastomers
WO2000021504A8 (en) Encapsulation of sensitive liquid components into a matrix to obtain discrete shelf-stable particles
AU3356297A (en) Thermoplastically processible starch or starch derivative polymer mixtures
CA2326137A1 (en) Method for stabilizing pharmaceutical compositions by special use of an antioxidant
WO2000009639A3 (en) Fatty ester combinations
BR9908578A (en) Cosmetic makeup
MY127430A (en) Solid lipid formulations comprising an inhibitor of lipases and a fatty acid ester of polyols
EP0757705A1 (en) Physically-modified degradable thermoplastic compositions
WO2000071789A8 (en) Hydrophilic polypropylene fibers having antimicrobial activity
KR19980700975A (en)
AU1973900A (en) Fuel additive and fuel composition containing the same
CA2091360A1 (en) Mometasone furoate monohydrate, process for making same and pharmaceutical compositions
CA2338684A1 (en) Injectable propofol formulations
CA2409828A1 (en) Formulation based in heparin, glycosaminoglycan or heparinoid, use of the formulation and the formulation base
WO1997007786A3 (en) Use of lipids as adjuvents in the production of solid medicinal forms by the melt extrusion process
CA2343130A1 (en) Cosmetic composition
DE69619979D1 (en) SOLID COMPOSITIONS WITH A NON-AMORPHOUS ACTIVE SUBSTANCE AND POLYETHYLENE OXIDE
KR960021018A (en) Pharmaceutical composition
AU5334894A (en) Compositions of fatty acid esters of hexitans
AU5058400A (en) Pharmaceutical composition containing an extrusion additive
AU554413B2 (en) Linoleic acid and essential fatty acid compositions as
AU3101300A (en) Compositions containing alpha-sulfofatty acid esters and methods of making and using the same
SE9602617D0 (en) An ortho ester based polymer, its preparation and use
AU1778200A (en) Moulding substances based on poly-C2-6-alkylene terephthalates
AU2326399A (en) 12-hydroxy stearic acid esters, compositions based upon same and methods of using and making such compositions

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase